NCT02647229

Brief Summary

The purpose of this physician blinded, randomized study is to determine the utility, effectiveness, and feasibility of using colonic irrigation as a substitute for standard oral colonic purgative solutions for colonoscopy preparation. Patients will be randomized to receive either oral isosmotic solution (PEG) or colonic irrigation using the Hydro San Plus Colon therapy system, an FDA approved and isosmotic (ISO) certified device for colonic irrigation and cleansing before endoscopic procedures.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 6, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

September 28, 2016

Status Verified

September 1, 2016

Enrollment Period

2 years

First QC Date

December 22, 2015

Last Update Submit

September 27, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison of Boston Bowel Prep Score (BBPS)

    Quality of bowel preparations validated by numerical scale for bowel cleanse (0-9 best)

    1 Day

Secondary Outcomes (4)

  • Difference in Adenoma Detection Rate (ADR)

    1 Day

  • Difference in the number of follow ups needed after colonoscopy

    1 Day

  • Difference in overall comfort and convenience between Colonic Hydrotherapy and Isosmotic Irrigation using Boston Bowel Preparation Score (BBPS)

    1 Day

  • preferences regarding type of bowel prep for future colonoscopy based on difference in score between Colonic Hydrotherapy and Isosmotic Irrigation using Boston Bowel Preparation Score (BBPS)

    1 Day

Study Arms (2)

Isosmotic bowel cleansing preparation

ACTIVE COMPARATOR

Isosmotic solution ingested prior to colonoscopy

Other: Isosmotic bowel cleansing preparation

Colonic Hyrdrotherapy

ACTIVE COMPARATOR

Colonic hydrotherapy is an FDA approved method of colon cleansing using constant warm water lavage with a contained temperature and pressure controlled device administered by a trained technician.2 There

Other: Colonic Hyrdrotherapy

Interventions

Isosmotic Preps contain polyethylene glycol (PEG) and are osmotically balanced, high-volume, nonabsorbable, and nonfermentable electrolyte solutions.

Isosmotic bowel cleansing preparation

FDA approved method of colon cleansing using constant warm water lavage with a contained temperature and pressure controlled device administered by a trained technician

Also known as: Hydro San Plus Colon therapy system
Colonic Hyrdrotherapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consecutive adult patients (\>18 years old) who require screening or surveillance colonoscopy
  • Ability to give consent

You may not qualify if:

  • Inability to obtain informed consent
  • Pregnant patients
  • Patients under the age of 18
  • Active ulcerative colitis or crohn's disease flare
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

Study Officials

  • Basil Lucak

    New York University Medical School

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2015

First Posted

January 6, 2016

Study Start

October 1, 2014

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

September 28, 2016

Record last verified: 2016-09

Locations